EPM
Equitec Proprietary Markets’s Ginkgo Bioworks DNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-12,200
| Closed | -$99.4K | – | 44 |
|
2024
Q3 | $99.4K | Sell |
12,200
-660,288
| -98% | -$5.38M | 0.08% | 11 |
|
2024
Q2 | $225K | Hold |
672,488
| – | – | 0.29% | 11 |
|
2024
Q1 | $780K | Sell |
672,488
-1,760,100
| -72% | -$2.04M | 0.48% | 11 |
|
2023
Q4 | $4.11M | Sell |
2,432,588
-95,500
| -4% | -$161K | 3.04% | 6 |
|
2023
Q3 | $4.58M | Sell |
2,528,088
-672,500
| -21% | -$1.22M | 1.13% | 5 |
|
2023
Q2 | $5.95M | Sell |
3,200,588
-445,062
| -12% | -$828K | 1.8% | 5 |
|
2023
Q1 | $4.85M | Sell |
3,645,650
-435,802
| -11% | -$580K | 2.29% | 5 |
|
2022
Q4 | $6.9M | Buy |
4,081,452
+1,795,187
| +79% | +$3.03M | 2.19% | 8 |
|
2022
Q3 | $7.13M | Sell |
2,286,265
-171,300
| -7% | -$534K | 1.88% | 8 |
|
2022
Q2 | $5.85M | Buy |
2,457,565
+795,109
| +48% | +$1.89M | 1.66% | 8 |
|
2022
Q1 | $6.7M | Buy |
1,662,456
+1,583,000
| +1,992% | +$6.38M | 1.47% | 6 |
|
2021
Q4 | $660K | Buy |
+79,456
| New | +$660K | 0.09% | 35 |
|